Management of inflammation in RVO

Macular edema (ME) is a leading cause of vision loss in retinal disease including retinal vein occlusion. The development of macular edema is mediated by angiogenic as well as Inflammatory processes. There is increasing evidence that management of the inflammatory part is important in the treatment of the edema. Therefore, theoretically steroid therapy has a good potential in the treatment of macular edema. Regarding retinal vein occlusion specifically treatment by Ozurdex implant, containing dexamethasoe provides visual recovery with excellent safety outcomes.